Meridia and Swallowing difficulty - a phase IV clinical study of FDA data

Summary:

Swallowing difficulty is reported as a side effect among people who take Meridia (sibutramine hydrochloride), especially for people who are female, 40-49 old, have been taking the drug for 1 - 6 months also take Premarin, and have Belching.

The phase IV clinical study analyzes which people have Swallowing difficulty when taking Meridia. It is created by eHealthMe based on reports of 6,763 people who have side effects when taking Meridia from the FDA, and is updated regularly.

What is Meridia?

Meridia has active ingredients of sibutramine hydrochloride. It is often used in weight loss. eHealthMe is studying from 6,939 Meridia users. Check the latest studies of Meridia.

What is Swallowing difficulty?

Swallowing difficulty is found to be associated with 2,401 drugs and 3,350 conditions by eHealthMe. Check the latest studies of Swallowing difficulty.

On Jul, 09, 2026

6,763 people reported to have side effects when taking Meridia.
Among them, 25 people (0.37%) have Swallowing difficulty.

Could Meridia cause Swallowing difficulty?

Among these 25 people:

How long have people been on Meridia when they have Swallowing difficulty? *

What is the gender of people who have Swallowing difficulty when taking Meridia? *

female: 95.83 %
male: 4.17 %

What is the age of people who have Swallowing difficulty when taking Meridia? *

What are other drugs people take besides Meridia? *

What are other side effects people have besides Swallowing difficulty? *

Fatigue (feeling of tiredness): 9 people, 36.00%
Weakness: 8 people, 32.00%
Chest Pain: 6 people, 24.00%
Dyskinesia (abnormality or impairment of voluntary movement): 6 people, 24.00%
Dyspnea (difficult or laboured breathing): 6 people, 24.00%
Emotional Disorder: 6 people, 24.00%
Tardive Dyskinesia (a disorder that involves involuntary movements): 6 people, 24.00%
Extrapyramidal Disorder (involuntary muscle spasms in the face and neck): 6 people, 24.00%
Heart Rate Increased: 6 people, 24.00%
Weight Increased: 5 people, 20.00%

What are the existing conditions these people have? *

Belching (release of gas from the digestive tract): 4 people, 16.00%
Asthma: 3 people, 12.00%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 8.00%
Weight Decreased: 1 person, 4.00%
Type 2 Diabetes: 1 person, 4.00%
Systemic Lupus Erythematosus (an autoimmune disease, which means the body's immune system mistakenly, attacks healthy tissue): 1 person, 4.00%
Sleep Disorder: 1 person, 4.00%
Seasonal Allergy (allergic condition due to certain season): 1 person, 4.00%
Premenstrual Syndrome: 1 person, 4.00%
Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 1 person, 4.00%

* Approximation only. Some reports may have incomplete information.

Do you take Meridia and have Swallowing difficulty?

- Check whether Swallowing difficulty is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Meridia:

Meridia (6,939 reports)

Browse all side effects of Meridia:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Swallowing difficulty:

Swallowing difficulty (2,401 drugs)

Browse all the conditions that are associated with Swallowing difficulty:

Swallowing difficulty (3,350 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on sibutramine hydrochloride (the active ingredients of Meridia) and Meridia (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.